Skyscape Web Viewer : Targeted Cancer Therapy A Handbook for Nurses : Main Index

View All
Nagata, Y.
Nail problems, EGFRI rash and nurse recommendations for
Nanoparticles
National Cancer Institute, Common Toxicity Criteria of Adverse Events
National Comprehensive Cancer Network Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) References (Chapter 2)
Natural killer cells Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Monoclonal Antibodies
N-cadherin
NCCN,
NCI,
Necrosis, apoptosis vs.
Neovastat (investigational) adverse reactions class mechanism of action Nursing Considerations and Drug Information reconstitution and administration
Nerve sprouting Hepatocyte Growth Factor (Hgf/C-Met) Receptor Pathway Targets Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways)
Neuregelin 1-4
Neuregulins
Neurofibromatosis Application Of The Hallmarks Of Cancer References
Neuropilin-1 (NRP1) Glossary Targeting Angiogenesis
Neuropilin-2 (NRP2) Glossary Targeting Angiogenesis
Neuropilins
Neutropenia, febrile
Neutrophils Application Of The Hallmarks Of Cancer Glossary Invasion and Metastasis Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Nursing Considerations and Drug Information
Nexavar,
NF-kB, ubiquitin-protease pathway's interaction with
NHL,
Nilotinib (Tasigna)
NK cells,
Nolvadex
Nonadherence Encouraging Patient Adherence and Persistence multicultural patients and issues with oral drug handling issues and predictors of References (Chapter 5)
Non-Hodgkin lymphoma
Nonreceptor tyrosine kinases Intracellular Signaling Kinases (E.g., Src, P13k/Akt/Mtor; Mapk; Sonic Hedgehog Pathways) Protein Kinase Signaling Pathways
Non-small cell lung cancer Antiangiogenic Drug Therapy EGFR overexpression in K-ras mutations and Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) References (Chapter 2) References (Chapter 3) Targeting Apoptosis